Sinopharm Vaccine

Britain said it would recognise COVID-19 vaccines on the World Health Organization's Emergency Use Listing later this month, adding China's Sinovac, Sinopharm and India's Covaxin to the country's approved list of vaccines for inbound travellers.

The WHO's vaccine advisors recommended Monday that people over 60 who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered a third Covid-19 vaccine dose.

Countries like Mongolia, Seychelles and Bahrain had relied on the easily accessible Chinese COVID-19 vaccines to combat the coronavirus pandemic and bring back normalcy. These countries are now battling a surge in infections.

Sri Lanka began injecting pregnant women with a Chinese coronavirus vaccine on Wednesday and Nepal resumed inoculations with a China-made jab as India's neighbours turn to Beijing and Moscow for help with supplies.

Vaccines from China's Sinopharm successfully contained Covid-19, according to a study published in a prestigious U.S. medical journal, the first time detailed findings from a late-stage trial of a Chinese shot have appeared in the scientific literatu

Bangladesh on Wednesday received 500,000 doses of China's Sinopharm COVID-19 vaccine as a gift to continue its vaccination drive, which was halted due to shortage of India-made Astrazeneca jabs.

The World Health Organization on Friday approved the Sinopharm Covid-19 vaccine for emergency use -- the first Chinese jab to receive the WHO's green light.

The United Arab Emirates and China on Sunday announced a venture to produce the Sinopharm coronavirus vaccine in the Gulf nation, state media reported.

Sri Lanka has put Chinese Sinopharm's COVID-19 vaccine on hold and will use India-manufactured Oxford AstraZeneca vaccine to inoculate 14 million people, a government spokesperson has said.

A Pakistan military aircraft brought back the country's first consignment of COVID-19 vaccines from China on Monday, the country's health adviser, Faisal Sultan, said.

Pakistan's Foreign Minister Shah Mehmood Qureshi said on Thursday that China has agreed to provide half a million doses of the Chinese Sinopharm COVID-19 free of cost to Pakistan by January 31.

Egypt has approved the use of a Covid-19 vaccine developed by Chinese pharma giant Sinopharm with its rollout to start later in January, the health minister said.

China was ahead in the global race to develop coronavirus vaccines with the most candidates in late stage of trials earlier in the year and its first approval of a homemade shot for the general public came on Thursday, yet with no detailed efficacy data.

Pakistan will purchase 1.2 million COVID-19 vaccine doses from China's Sinopharm , a minister said on Thursday, the first official confirmation of a vaccine purchase by the South Asian country as it battles a second wave of infections.

China approved its first COVID-19 vaccine for general public use on Thursday, a shot developed by an affiliate of state-backed pharmaceutical giant Sinopharm, as it braces for greater transmission risks over the winter.

Britain said it would recognise COVID-19 vaccines on the World Health Organization's Emergency Use Listing later this month, adding China's Sinovac, Sinopharm and India's Covaxin to the country's approved list of vaccines for inbound travellers.

The WHO's vaccine advisors recommended Monday that people over 60 who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered a third Covid-19 vaccine dose.

Countries like Mongolia, Seychelles and Bahrain had relied on the easily accessible Chinese COVID-19 vaccines to combat the coronavirus pandemic and bring back normalcy. These countries are now battling a surge in infections.

Sri Lanka began injecting pregnant women with a Chinese coronavirus vaccine on Wednesday and Nepal resumed inoculations with a China-made jab as India's neighbours turn to Beijing and Moscow for help with supplies.

Vaccines from China's Sinopharm successfully contained Covid-19, according to a study published in a prestigious U.S. medical journal, the first time detailed findings from a late-stage trial of a Chinese shot have appeared in the scientific literatu

Bangladesh on Wednesday received 500,000 doses of China's Sinopharm COVID-19 vaccine as a gift to continue its vaccination drive, which was halted due to shortage of India-made Astrazeneca jabs.

The World Health Organization on Friday approved the Sinopharm Covid-19 vaccine for emergency use -- the first Chinese jab to receive the WHO's green light.

The United Arab Emirates and China on Sunday announced a venture to produce the Sinopharm coronavirus vaccine in the Gulf nation, state media reported.

Sri Lanka has put Chinese Sinopharm's COVID-19 vaccine on hold and will use India-manufactured Oxford AstraZeneca vaccine to inoculate 14 million people, a government spokesperson has said.

A Pakistan military aircraft brought back the country's first consignment of COVID-19 vaccines from China on Monday, the country's health adviser, Faisal Sultan, said.

Pakistan's Foreign Minister Shah Mehmood Qureshi said on Thursday that China has agreed to provide half a million doses of the Chinese Sinopharm COVID-19 free of cost to Pakistan by January 31.

Egypt has approved the use of a Covid-19 vaccine developed by Chinese pharma giant Sinopharm with its rollout to start later in January, the health minister said.

China was ahead in the global race to develop coronavirus vaccines with the most candidates in late stage of trials earlier in the year and its first approval of a homemade shot for the general public came on Thursday, yet with no detailed efficacy data.

Pakistan will purchase 1.2 million COVID-19 vaccine doses from China's Sinopharm , a minister said on Thursday, the first official confirmation of a vaccine purchase by the South Asian country as it battles a second wave of infections.

China approved its first COVID-19 vaccine for general public use on Thursday, a shot developed by an affiliate of state-backed pharmaceutical giant Sinopharm, as it braces for greater transmission risks over the winter.